Physician profile
Ewaul Persaud
NPI 1730468299
$6,447.75
in general payments reported to CMS, 2019-2025
43 companies · $810 in 2025
The $810 reported for 2025 was more than what 81% of Adult Medicine providers received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,621 · 2020: $1,072 · 2021: $183 · 2022: $749 · 2023: $438 · 2024: $574 · 2025: $810.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,822.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,822.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,046.69 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $917.31 | 2019-2025 | Farxiga, Breztri |
| Abbvie INC. | $529.60 | 2021-2025 | |
| Lilly USA, LLC | $464.63 | 2019-2025 | Mounjaro, Zepbound |
| Pfizer INC. | $312.95 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $254.86 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $252.09 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $225.23 | 2019-2020 | |
| Amarin Pharma, INC. | $197.48 | 2019-2022 | |
| Exact Sciences Corporation | $178.99 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Arbor Pharmaceuticals, INC. | $169.21 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $165.21 | 2019-2020 | |
| Allergan, INC. | $162.77 | 2019-2020 | |
| Optinose US, INC. | $135.19 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $130.86 | 2022 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ewaul Persaud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.